Patient related strategy |
Establishment of cell cultures for each individual patient |
Cell lines with candidate variants applicable to multiple patients |
Informed consent from patient |
Cell culture establishment and maintenance |
Genetic screening (identification of epilepsy related variant) |
Cell model genetic background |
Patient specific |
Establish and well characterized |
Cell model system development |
Isolation of patient derived cells |
Genetic manipulations of cell lines |
Introduction of gene variants |
No |
Particular epilepsy related variants need to be introduced |
Control samples |
Isogenic cell line or non affected tissue |
Parental cell line |